A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis

A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis

Abstract Background Reliable assessment of remission is important for the optimal management of rheumatoid arthritis (RA) patients. In this study, we used the multi-biomarker disease activity (MBDA) test to explore the role of biomarkers in predicting point remission and sustained remission. Methods...

Full description

Bibliographic Details
Main Authors: M. H. Y. Ma, N. Defranoux, W. Li, E. H. Sasso, F. Ibrahim, D. L. Scott, A. P. Cope
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Remission
MBDA score
IL6
SAA
Leptin
Online Access:http://link.springer.com/article/10.1186/s13075-020-02240-w

Internet

http://link.springer.com/article/10.1186/s13075-020-02240-w

Similar Items